Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

2.8000

-0.1500

(-5.08%)

At close: 04:00PM EDT

2.7900

-0.01

(-0.36%)

After hours:

07:58PM EDT

Loading interactive chart...

GlobeNewswire
Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC’s Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports
Public-private partnership to enable the development of innovative, sustainable infrastructure designed to set the global standard for travel biosecurityBOSTON and NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Ginkgo Bioworks (NYSE: DNA) and XpresSpa Group, Inc. (Nasdaq: XSPA) announced they will continue to support the Centers for Disease Control and Prevention’s (CDC’s) traveler-based SARS-CoV-2 genomic surveillance program through a new contract awarded August 12, 2022. The partnership is expec
Yahoo Finance Video
Ginkgo Bioworks partners with Synlogic on new gout drug
Ginkgo is teaming up with Synlogic to launch a new gout drug, moving shares of both stocks higher.
Simply Wall St.
Is Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Trading At A 33% Discount?
Today we will run through one way of estimating the intrinsic value of Ginkgo Bioworks Holdings, Inc. ( NYSE:DNA ) by...